Pursuant to Regulation 47 of SEBI Listing Regulations, 2015, enclosed here with copies of Newspaper publications providing Audited financial results for the Quarter and Year ended March 31st, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals Ltd has submitted copies of newspaper advertisements containing its audited financial results for the quarter and full year ended March 31, 2025, as required under Regulation 47 of the SEBI Listing Regulations. The advertisements were published in Financial Express (English) and Nava Telangana (Telugu) on May 10, 2025. The same results have also been made available on the company's website at www.venmaxdrugs.com. The company is listed on BSE with scrip code 531015 and is headquartered in Hyderabad. No specific financial figures are disclosed in the cover letter itself.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that the audited FY25 results were published in newspapers as mandated, giving public visibility to the numbers.